Switzerland announces outcomes from triennial drug price review
Switzerland’s latest review of drug prices has reduced prices on half of the medicines reviewed. Every year Switzerland’s Bundesamt für … read more »
Labour Party Conference presents proposals on medicine pricing
The Leader of the Opposition, the Rt Hon Jeremy Corbyn MP, gave his address to the Labour Party Conference on … read more »
Substantial changes to Medicine regulations in Canada from July 2020
Significant changes have been published, due to come into force in 2020, affecting the countries used by Canada in international … read more »
US lawmakers seek answers on generic medicine pricing from industry
The Chairman of the House Committee on Oversight and Reform, Rep. Elijah Cummings, and Senator Bernie Sanders have written to … read more »
Pricing transparency proposals challenged by EFPIA
EFPIA has opposed a price sharing proposal between EU countries suggesting that this could reduce incentives for pharmaceutical companies to … read more »
President may use executive order to reduce price of certain drugs
President Trump has announced a forthcoming executive order designed to lower certain drug costs by pegging them to the lowest … read more »
Canadian Federal Court rules PMPRB decision fair
The Canadian Federal Court has ruled that a decision from PMPRB regarding the pricing of Soliris should stand. Alexion Pharmaceutical’s … read more »
Study claims drugs prices are likely to continue to increase in the US due to rebate system
A study by Scripps has claimed that drug prices are likely to continue to increase in the US due to … read more »
ABPI publishes views on access to Orkambi
The Chief Executive of the ABPI Executive Director, Dr Richard Torbett, has published a statement on medicines pricing and the … read more »
WHO adopts resolution on transparency in drug pricing
Members of the WHO have agreed to push governments to demand greater transparency from companies in drug pricing. The World … read more »
